Jan 11 (Reuters) - Halozyme Therapeutics Inc :
* 2021 REVENUE GUIDANCE OF $375 TO $395 MILLION
* 2021 EPS GUIDANCE OF $1.40 TO $1.55
* FY2021 EARNINGS PER SHARE VIEW $1.79, REVENUE VIEW $403.7 MILLION -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* 2021 REVENUE GUIDANCE OF $375 TO $395 MILLION
* 2021 EPS GUIDANCE OF $1.40 TO $1.55
* FY2021 EARNINGS PER SHARE VIEW $1.79, REVENUE VIEW $403.7 MILLION -- REFINITIV IBES DATA
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)